22 May 2024
22 May 2024
The Tina-quant Lp(a) RxDx assay is designed to identify patients who may benefit from therapies aimed at decreasing Lp(a) levels.
The study will take place at Harvard’s Brigham and Women's Hospital and will validate AiM’s robot for deep brain stimulation in Parkinson’s.
As per the statement of policy intent, the UK intends to acknowledge regulatory approvals from specific countries.
Cochlear is set to integrate the acquired business over the coming months.
The company has secured a cumulative $24m from high-net-worth individuals and NIH grants to date.
SonarMD's digital platform uses predictive analytics to identify clinical deterioration in IBD patients before they become emergencies.
Guardant Health’s liquid biopsy was the first FDA-approved blood test for genomic testing of solid tumours.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
